|
CKAP2L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.19779999649705E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.68189999999857E-05 |
| Normal-vs-Stage2 |
5.248300E-04 |
| Normal-vs-Stage3 |
8.08060000023758E-07 |
| Normal-vs-Stage4 |
7.58170000000336E-05 |
| Stage1-vs-Stage2 |
4.713400E-01 |
| Stage1-vs-Stage3 |
2.102100E-02 |
| Stage1-vs-Stage4 |
5.196600E-03 |
| Stage2-vs-Stage3 |
2.904200E-01 |
| Stage2-vs-Stage4 |
1.635770E-02 |
| Stage3-vs-Stage4 |
5.077900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.77200000228694E-08 |
| Normal-vs-AfricanAmerican |
2.947800E-02 |
| Normal-vs-Asian |
2.208200E-01 |
| Caucasian-vs-AfricanAmerican |
4.3836999999991E-05 |
| Caucasian-vs-Asian |
5.724400E-01 |
| AfricanAmerican-vs-Asian |
3.293600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.23090000204007E-08 |
| Normal-vs-Female |
1.90265999999717E-05 |
| Male-vs-Female |
1.006840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.581900E-03 |
| Normal-vs-Age(41-60Yrs) |
2.23369999996503E-06 |
| Normal-vs-Age(61-80Yrs) |
2.49870000024188E-07 |
| Normal-vs-Age(81-100Yrs) |
2.502300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.915000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.636800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.031000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.175400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.991600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.586070E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.062100E-02 |
| Normal-vs-Grade 2 |
4.01620000000102E-05 |
| Normal-vs-Grade 3 |
1.25100000025746E-07 |
| Normal-vs-Grade 4 |
1.431030E-04 |
| Grade 1-vs-Grade 2 |
2.568300E-02 |
| Grade 1-vs-Grade 3 |
4.764200E-04 |
| Grade 1-vs-Grade 4 |
1.483200E-03 |
| Grade 2-vs-Grade 3 |
3.286100E-02 |
| Grade 2-vs-Grade 4 |
7.000500E-03 |
| Grade 3-vs-Grade 4 |
2.401600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.8002000000037E-05 |
| Normal-vs-ccB subtype |
2.4305000001501E-07 |
| ccA subtype-vs-ccB subtype |
1.144330E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.70309999997431E-07 |
| Normal-vs-N1 |
1.943770E-03 |
| N0-vs-N1 |
1.426230E-02 |
|
|
